NEW YORK (Reuters) - Express Scripts Inc will buy health insurer WellPoint Inc's NextRx prescription business for $4.68 billion, becoming the No. 2 U.S. pharmacy benefit manager while gaining more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback